
The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

The 2026-2027 vaccine targets the XFG variant to more closely match current variants

Rinvoq is the first and only systemic medication approved in the EU for NSV

Cases of measles have been rising in Europe since 2023

The scheme supports the development of treatments targeting unmet medical needs in the EU

This type of cancer is the most common one diagnosed in teenagers

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio

Even with countermeasures in place, European auditors warn that the risks remain elevated

Marketing authorisation follows positive late-stage trial results

On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment

Globally, five billion doses of the companies’ vaccine have been distributed